Lungs SLO Practice (online) Page 1 of 5
|
|
|
- Muriel Stevens
- 5 years ago
- Views:
Transcription
1 Lungs SLO Practice (online) Page 1 of 5 1. A 15 year- old teen has asthma. A nebulizer treatment has been ordered. The type of medication most likely to be used in this treatment for asthma management is: A. A leukotriene receptor blocker B. A corticosteroid C. A LOX inhibitor or Leukotriene modifier D. A beta blocker E. A beta (2) agonist 2. A client with asthma asks which prescribed medication should be used to treat an acute episode of bronchospasm. The nurse knows the client should use: A. Fluticasone, by mouth B. Albuterol, by inhalation. C. Ipratropium, by inhalation D. Montelukast, by mouth E. Theophylline, by mouth 3. Acetylcysteine is associated with? A. Tachycardia and increased blood pressure, C. Tachycardia, blood pressure changes, flushing, nausea, vomiting, bronchospasm, and anaphylaxis at any time during therapy D. Sedation, psychic and physical dependence, E. Significant antimuscarinic effects. 4. Albuterol (Proventil) is a(n): A. Mixed alpha and beta catecholamine used to treat anaphylaxis B. Antimuscarinic bronchodilator for COPD D. LT receptor antagonist for asthma and 5. An asthma patient is prescribed a Flunisolide (AeroBid) inhaler. Which of the following is an education point covered by the astute nurse? A. "Rinse your mouth after each use." B. "You should feel tired after using this drug." C. "Take as soon as you experience bronchoconstriction." D. "This drug will protect you from superinfections caused by antibiotics." E. "Flunisolide will reverse status asthmaticus, so make sure to always carry your inhaler." 6. Budesonide (Rhinocort Aqua) is a: A. Topical non- steroid nasal decongestant B. Sympathomimetic (alpha agonist) topical nasal C. Beta 2 agonist for asthma D. Topical and orally inhaled steroid nasal also available PO for Crohn s E. Sympathomimetic (alpha agonist) oral nasal 7. Dextromethorphan (DXM, DM) is a: A. C- III narcotic Opioid antitussive/analgesic with B. Topical and orally inhaled steroid nasal C. Non- narcotic Opioid NMDA antagonist D. Xanthine bronchodilator E. Sympathomimetic (alpha agonist) topical nasal 8. Dextromethorphan is associated with? A. Sedation, psychic and physical dependence, C. Tachycardia and increased blood pressure, D. Significant antimuscarinic effects. E. Vomiting when taken in excess.
2 Lungs SLO Practice (online) Page 2 of 5 9. Diphenhydramine (Benadryl) is a: A. Mucolytic when inhaled, antidote to APAP OD B. Corticosteroid anti- inflammatory. C. Xanthine Bronchodilator for asthma & COPD D. 2 nd generation antihistamine indicated to treat E. 1 st generation antihistamine and 10. Drugs that convert a dry cough to a productive cough (to clear phlegm) are called: C. Mucolytic D. Surfactant E. Expectorant 11. Drugs that decrease the amount of mucous or edema produced due to colds or are called: B. Mucolytic C. Expectorant D. Surfactant E. Decongestant 12. Drugs that replace the natural lubricant in the lung are called: B. Surfactant C. Mucolytic E. Decongestant 13. Drugs that suppress coughing are called: A. Surfactant C. E. Mucolytic 14. Drugs that thin mucous in the upper airwys by chemically removing sulphur cross- linkages in mucoproteins are called: C. Surfactant E. Mucolytic 15. Epinephrine (EpiPen) is a(n): A. Xanthine Bronchodilator for asthma or COPD C. Beta- 2 agonist bronchodilator D. Mixed alpha and beta catecholamine used to treat anaphylaxis E. Antimuscarinic bronchodilator for COPD 16. Fexofenadine (Allegra) is a: A. Xanthine Bronchodilator for asthma & COPD B. Corticosteroid anti- inflammatory. C. Mucolytic when inhaled, antidote to APAP OD D. 1 st generation antihistamine and E. 2 nd generation antihistamine indicated to treat 17. Flunisolide (AeroBid) is a: A. Sympathomimetic (alpha agonist) topical nasal B. Xanthine bronchodilator C. Topical and orally inhaled steroid anti D. Beta 2 agonist bronchodilator E. Injectable steroid nasal decongestant 18. Fluticasone (Flonase) is a: A. Topical and orally inhaled steroid anti B. Topical non- steroidal nasal decongestant C. Xanthine bronchodilator D. Orally inhaled Beta 2 agonist bronchodilator E. Sympathomimetic (alpha agonist) topical nasal
3 Lungs SLO Practice (online) Page 3 of Hydrocodone with homatropine (Hycodan) is a: A. C- III narcotic Opioid antitussive/analgesic with B. Sympathomimetic (alpha agonist) topical nasal C. Topical and orally inhaled steroid nasal D. Non- narcotic Opioid NMDA antagonist E. Sympathomimetic (alpha agonist) oral nasal 20. Hydrocodone with homatropine is associated with? A. Nasal burning, epistaxis, nasal dryness, B. Significant sympathetic effects. C. Sedation, psychic and physical dependence, D. Vomiting when taken in excess. E. Tachycardia and increased blood pressure, 21. Ipratropium (Atrovent) is a(n): A. Antimuscarinic bronchodilator for COPD D. Mixed alpha and beta (mostly beta) synthetic 22. Isoproterenol (Isuprel) is a(n): A. LT receptor antagonist for asthma and B. Beta- 2 agonist bronchodilator C. Antimuscarinic bronchodilator for COPD D. Xanthine Bronchodilator for asthma or COPD E. Mixed alpha and beta (mostly beta) synthetic 23. Mometasone (Nasonex) is a: A. Topical and orally inhaled steroid anti B. Sympathomimetic (alpha agonist) oral nasal C. Topical non- steroidal nasal decongestant D. Sympathomimetic (alpha agonist) topical nasal E. Beta 2 agonist bronchodilator 24. Montelukast (Singulair) is a(n): A. Mixed alpha and beta (mostly beta) synthetic D. Antimuscarinic bronchodilator for COPD 25. Oxymetazoline (Afrin) is a: A. Non- narcotic Opioid NMDA antagonist B. C- III narcotic Opioid antitussive/analgesic with C. Topical and orally inhaled steroid nasal D. Sympathomimetic (alpha agonist) topical nasal E. Sympathomimetic (alpha agonist) topical spray nasal 26. Pseudoephedrine (Sudafed) is a: A. Topical and orally inhaled steroid nasal B. C- III narcotic Opioid antitussive/analgesic with C. Sympathomimetic (alpha agonist) oral nasal D. Xanthine Bronchodilator for asthma or COPD E. Beta 2 agonist for asthma
4 Lungs SLO Practice (online) Page 4 of The First Generation Antihistamines are associated with? A. Tachycardia and increased blood pressure, vomiting, dry mouth, and urinary retention. C. Significant antimuscarinic effects. D. Vomiting when taken in excess. E. Sedation, psychic and physical dependence, 28. The sympathomimetic bronchodilators are associated with? A. Significant antimuscarinic effects. B. Sedation, psychic and physical dependence, C. Tachycardia and increased blood pressure, D. Tachycardia, anxiety and sweating E. Nasal burning, epistaxis, nasal dryness, 29. The sympathomimetic decongestants are associated with? A. Vomiting when taken in excess. B. Significant antimuscarinic effects. C. Nasal burning, epistaxis, nasal dryness, D. Sedation, psychic and physical dependence, E. Tachycardia and increased blood pressure, 30. The topically applied corticosteroids are associated with? A. Sedation, psychic and physical dependence, B. Tachycardia and increased blood pressure, C. Significant antimuscarinic effects. D. Nasal burning, epistaxis, nasal dryness, E. Vomiting when taken in excess. 31. Theophylline (Theo- 24) is a: A. Oral expectorant to move phlegm out of airways B. Xanthine Bronchodilator for asthma & COPD C. 2 nd generation antihistamine indicated to treat D. 1 st generation antihistamine and E. Mucolytic when inhaled, antidote to APAP OD 32. Which of the following OTC cold products will NOT help alleviate cough associated with colds or? A. Phenylephrine B. Dextromethorphan C. Guaifenesin D. Diphenhydramine E. All of the above 33. Zafirlukast (Accolate) is a(n): A. LT receptor antagonist for asthma and B. Beta- 2 agonist bronchodilator C. Antimuscarinic bronchodilator for COPD D. Mixed alpha and beta (mostly beta) synthetic E. Xanthine Bronchodilator for asthma or COPD
5 Lungs SLO Practice (online) Page 5 of Amantadine is a(n): A. Mast cell stabilizer (inhibits the release of B. Neuraminidase inhibitor against Influenza A C. Topical steroid nasal decongestant D. Ion channel M2 protein inhibitor on Influenza E. Lung surfactant replacement (natural bovine 38. Zanamivir is a(n): A. Neuraminidase inhibitor against Influenza A B. Topical steroid nasal decongestant C. Ion channel M2 protein inhibitor on Influenza D. Lung surfactant replacement (natural bovine E. Mast cell stabilizer (inhibits the release of 35. Beractant (Survanta) is a(n): A. Ion channel M2 protein inhibitor on Influenza B. Topical steroid nasal decongestant C. Neuraminidase inhibitor against Influenza A D. Lung surfactant replacement (natural bovine E. Mast cell stabilizer (inhibits the release of 36. Cromolyn is a(n): A. Neuraminidase inhibitor against Influenza A B. Ion channel M2 protein inhibitor on Influenza C. Topical steroid nasal decongestant D. Mast cell stabilizer (inhibits the release of E. Lung surfactant replacement (natural bovine 37. Oseltamivir is a(n): A. Lung surfactant replacement (natural bovine B. Ion channel M2 protein inhibitor on Influenza C. Mast cell stabilizer (inhibits the release of D. Topical steroid nasal decongestant E. Neuraminidase inhibitor against Influenza A
31 - Respiratory System
31 - Respiratory System Asthma 1. Asthma has two components. Name the two components. 2. What are the common triggers of asthma? (LP p319) (e.g., pets) Upper respiratory infections ( ) 3. Describe a normal
ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component
ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate
Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
Allergy and inflammation
and inflammation 1 Allergic population hyper-producers of IgE consistently increasing western societies: ~20% of general population 2 Allergic population 3 Allergic triggers 4 Allergic triggers abnormal
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section.
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACLIDINIUM BROMIDE bronchodilators ADRENALINE/EPINEPHRINE
Foundations of Pharmacology
Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids
Methacholine Challenge Test
PATIENT & CAREGIVER EDUCATION Methacholine Challenge Test This information will help you prepare for your methacholine challeng e test at Memorial Sloan Kettering (MSK). A methacholine (meth-a-kole-leen)
Pharmacotherapy for Allergic Rhinitis
Pharmacotherapy for Allergic Rhinitis William Reisacher, MD FACS FAAOA Assistant Professor Weill Cornell Medical College The Impact of Allergic Rhinitis Allergic rhinitis affects approximately 50 million
Drugs Used to Treat Chronic Obstructive Pulmonary Disease (COPD)
Drugs Used to Treat Chronic Obstructive Pulmonary Disease (COPD) COPD COPD is a chronic, irreversible obstruction of airflow that is usually progressive. Symptoms include cough, excess mucus production,
Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.
Asthma Asthma Description Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Symptoms of asthma In susceptible individuals, this inflammation causes recurrent
Triage Information: 1. Duration of HPSJ Membership 2. Age 3. Fill history of Seasonal Allergy Medications
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Seasonal Allergy Medications LAST REVIEW: 5/28/2015 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 5/15, 9/14
기관지확장제와기관지천식 치료에쓰이는약물 이종호 한림의대약리학교실
기관지확장제와기관지천식 치료에쓰이는약물 이종호 한림의대약리학교실 천식치료제 기관지확장제 Beta2 adrenergic agonists; terbutaline, albuterol, metaproterenol, salmeterol Muscarinic antagonists; Ipratropium Methylxanthines; theophylline 예방및항염증약물
Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Seasonal Allergy Medications LAST REVIEW: 9/20/2016 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 5/16, 5/15,
Disclosure. OTC Review with a Pediatric Twist. Objectives. When to Call a Doctor for Infant. When to Call a Doctor for Child
OTC Review with a Pediatric Twist Disclosure Consultant for Johnson and Johnson Baby Jill A. Morgan, PharmD, BCPS February 2015 Objectives List situations when a child should be referred to physician.
Medications Affecting The Respiratory System
Medications Affecting The Respiratory System Overview Asthma is a chronic inflammatory disorder of the airways. It is an intermittent and reversible airflow obstruction that affects the bronchioles. The
II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical
Table 3.1. Classification of COPD Severity Stage Pulmonary Function Test Findings Symptoms I: Mild Mild airflow limitations +/ Chronic cough and sputum production; patient unaware of abnormal FEV 1 80%
Chapter 55. Changes in the Airway With COPD. Manifestations of Severe COPD. Drugs Used to Treat Obstructive Pulmonary Disorders
Chapter 55 Drugs Used to Treat Obstructive Pulmonary Disorders Changes in the Airway With COPD Manifestations of Severe COPD Air is trapped in the lower respiratory tract The alveoli degenerate and fuse
Oral Agents. Fml Limits. Available Strengths NF NF
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Allergy Medications LAST REVIEW: 9/12/2017 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 9/16, 5/15, 9/14
Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
3 RESPIRATORY SYSTEM
3 RESPIRATORY SYSTEM 3.01 ANTIASTHMATICS 3.01a BETA 2 AGONIST ASTHMA, CHRONIC BRONCHITIS & EMPHYSEMA Salbutamol Inhaler 100ug/dose [Albuterol] (Ventolin) Salbutamol Sulphate Respirator Solution 0.5% (5mg/ml),
Advanced Pharmacology Respiratory Pharmacology
Advanced Pharmacology Respiratory Pharmacology Thomas W. Barkley, Jr., PhD, ACNP BC, FAANP President, Barkley & Associates www.npcourses.com and Professor of Nursing Director of Nurse Practitioner Programs
ALLERGIC RHINOSINUSITIS. Sirisha A Post graduate Dept of Pharmacology Kamineni Institute of Medical Sciences
ALLERGIC RHINOSINUSITIS Sirisha A Post graduate Dept of Pharmacology Kamineni Institute of Medical Sciences OVERVIEW Pathophysiology Goals of therapy Approaches to therapy Antihistaminics Corticosteroids
Atrovent Administration
Atrovent Administration ICEMA Training 2007 Sherri Shimshy RN OBJECTIVES Describe the pharmacology of Atrovent Identify the indications for use of Atrovent in the Adult Population Identify the indications
PRINCIPAL MEDICATION OPTIONS FOR RHINITIS
SEE INDICATED SUMMARY STATEMENT (SS#) DISCUSSION FOR SUPPORTING DATA ALLERGIC RHINITIS (AR): SEASONAL (SAR) AND PERENNIAL (PAR) MONOTHERAPY ORAL Antihistamines, oral (H1 receptor antagonists) (SS# 61-64)
Pharmacology Drugs of Respiratory system. Drugs acting on respiratory system. Dr. Ahmad Al-Zohyri Lec. 11
Drugs acting on respiratory system Dr. Ahmad Al-Zohyri Lec. 11 Respiratory system is subjected to a lot of injurers and harms because it is nearly the only system which is in continuous contact with the
Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources
Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency
Pharmacodynamics. Drugs usually elicit more than one effect. What the drug does to the body. How do drugs work? What do they do?
Pharmacology 203 Windward Community College Pharmacodynamics What the drug does to the body How do drugs work? What do they do? In this fact sheet, we will look at the fundamental mechanisms of drug action.
JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEO RDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY
JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEO RDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY HERE ARE TODAY S CATEGORIES Theme Timer Correct Wrong Boo Silence Pharmacology Theme Timer Correct Wrong
Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma
Page 1 of 8 PED-ALL-005-1992 Asthma Medications: Information for Children and Families What You Need to Know about Medicines for Asthma What Medicines Are used to Treat Asthma? There are two kinds of medicines:
Respiratory Pharmacology
Allergy Targets of allergies Type I Histamine Leukotrienes Prostaglandins Bradykinin Hypersensitivity reactions Asthma Characterised by Triggered by Intrinsic Extrinsic (allergic) Mediators Result Early
Jagdeep Hundal, MD, Otolaryngology, Head & Neck Surgery 774 Christiana Rd, Suite B4, Newark, DE Phone: Fax:
Allergy Questionnaire Patient Name Date / / 1. What symptoms do you suffer from? Please circle below Eyes: Itchy eyes, tearing, eye redness, eye discharge Ears: Popping sensation, fullness, itching Nose/Sinus:
There is no such thing as a safe drug. All drugs have the ability to cause injury.
Pulmonary System 4 There is no such thing as a safe drug. All drugs have the ability to cause injury. Richard A. Lehne PRACTICE QUESTIONS A Client with an Upper Respiratory Infection 1. The client diagnosed
Asthma. Definition. Symptoms
Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution
Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma
Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going
Matt Stumpe, MD Otolaryngologist Mid Kansas Ear, Nose, & Throat
Matt Stumpe, MD Otolaryngologist Mid Kansas Ear, Nose, & Throat Inflammation of the nasal mucosa secondary to an inappropriate hypersensitivity reaction to an allergen IgE mediated immune response with
Pharmacology of drugs used in bronchial asthma & COPD
Pharmacology of drugs used in bronchial asthma & COPD By Prof. Hanan Hagar Pharmacology Unit King Saud University ILOs: The students should be able to 1. Different types of drugs used for treatment of
REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE
REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE ID NUMBER: 0a) Date of Collection / / 0b) Staff Code Instructions: This form should be completed during the participant s clinic visit. 1) Are you regularly
Breath of Fresh Air. Information, news and advice for improving asthma well-being. National Asthma Guidelines: A Stepped Approach to Asthma Therapy
Information, news and advice for improving asthma well-being Volume 11, No. 1 Summer 2008 National Asthma Guidelines: A ped Approach to Asthma Therapy In the last issue of Breath of Fresh Air, we discussed
Respiratory Pharmacology. Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France
Respiratory Pharmacology Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France Programme Bronchomotor tone Drugs and factors influencing airway
Drugs Affecting the Respiratory System
Drugs Affecting the Respiratory System Drugs Affecting the Respiratory System Antihistamines, Decongestants, Antitussives, and Expectorants COUGH with presence of secretion in bronchi dry PRODUCTIVE Sputum
500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device
3.1 BRONCHODILATORS 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol Terbutaline 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated e.g. Easi-Breathe 200 micrograms/dose
PREPARATION FOR ALLERGY TESTING *** Please read this information at least one week before your upcoming visit.
PREPARATION FOR ALLERGY TESTING *** Please read this information at least one week before your upcoming visit. In order to obtain valid and useful skin testing results, you will need to stop the use of
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCIDENCE UP TO 380,000 PEOPLE IN IRELAND HSE FIGURES 110,000 DIAGNOSED AND 200,000 UNDIAGNOSED. AFFECTS MORE MEN THAN WOMEN BUT RATES ARE RISING 1500 DEATHS PER YEAR
Asthma By Mayo Clinic staff
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
Better Living with Obstructive Pulmonary Disease A Patient Guide
Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health a Better Living with Chronic Obstructive Pulmonary Disease A Patient Guide is a joint project
Respiratory Pharmacology. Pharmacology. Clinical Pharmacology. farmakon. pharmakon. Medicine Poison Magic Spell
1 Respiratory Pharmacology Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand 2 Pharmacology is derived from a Greek word (pharmakon). The Greeks used this word
RESPIRATORY PHARMACOLOGY
Yerevan State Medical University Department of Anaesthesiology and Intensive Care Yerevan, Armenia RESPIRATORY PHARMACOLOGY Dr. Armen VAROSYAN Associate Professor, DEAA, PhD Lecture Outline Drugs stimulating
Principles of Pharmacology. Copyright 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved.
Principles of Pharmacology Principles of Pharmacology Objectives: Distinguish government agencies that regulate drugs in the USA. List DEA regulations and the five scheduled controlled substances. Explain
Clinical Indications. Clinical Indications. RSPT 2317 Methylxanthines. RSPT 2317 Methylxanthines
RSPT 2317 Clinical Indications Theophylline management of asthma and COPD treatment of apnea of prematurity (AOP) diuretic (obsolete use) classified as a bronchodilator, but is weaker than β agonists effects
Sinusitis. What are the sinuses? Who develops sinusitis?
Sinusitis Health experts estimate that 37 million Americans are affected by sinusitis every year. Americans spend nearly $6 billion each year on health care costs related to sinusitis. Sinusitis is an
RESPIRATORY PHARMACOLOGY - ASTHMA. Primary Exam Teaching - Westmead ED
RESPIRATORY PHARMACOLOGY - ASTHMA Primary Exam Teaching - Westmead ED Sympathomimetic agents MOA: relax airway smooth muscle and inhibit broncho constricting mediators from mast cells May also inhibit
Significance. Asthma Definition. Focus on Asthma
Focus on Asthma (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Asthma Definition Chronic inflammatory disorder of airways Causes airway hyperresponsiveness
BNF CHAPTER 3: RESPIRATORY
3.1 BRONCHODILATORS BNF CHAPTER 3: RESPIRATORY 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated (e.g., Easi-Breathe
From the Text. Clinical Indications. Clinical Indications. Clinical Indications. Clinical Indications. RSPT 2317 Methylxanthines
From the Text RSPT 2217 Gardenhire Chapter 8 Key Terms and Definitions page 151 Xanthine Derivatives Used as Bronchodilators Table 8-1; page 152 Adverse Reactions Seen with Theophylline Box 8-1; page 157
Steven Berkowitz, DVM Chief, Emergency and Critical Care Saint Francis Veterinary Center
Steven Berkowitz, DVM Chief, Emergency and Critical Care Saint Francis Veterinary Center Outline Anatomy Common Diseases Interventions Oxygen Therapy Medications Nebulization Coupage Respiratory Tract
Case Study. Allergic Rhinitis 5/18/2015
John A. Fling, M.D. Professor Allergy/Immunology University of North Texas Health Science Center, Fort Worth, Texas Case Study 38 year old male with a history of nasal congestion, clear nasal discharge
Drug Profiles Professional Responder
Entonox Classification Medical Gas Entonox (50% oxygen 50% nitrous oxide) Effects Potent analgesic, weak anesthetic Onset Rapid Peak Immediate Indications Relief of moderate to severe pain Cardiac-related
Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management
Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management Table of Contents Policy: Commercial Information Pertaining to All Policies Endnotes Policy: Medicare References
3. Respiratory System
1 3. Respiratory System Also see Appendix 3A Guidance on Management of Also see Appendix 3B Preferred Inhaler Devices for Adults Also see Appendix 3C Preferred Inhaler Devices for Adolescents (12-18 years)
Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Respiratory Subcommittee minutes for web publishing
Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Respiratory Subcommittee minutes for web publishing Respiratory System and Allergies therapeutic group PTAC and Subcommittee
2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information
ASTHMA & COPD The Yin &Yang Arizona State Association of Physician Assistants March 6, 2015 Sedona, Arizona Randy D. Danielsen, PhD, PA-C, DFAAPA Dean & Professor A.T. Still University Asthma General Information
Nursing Process Focus: Patients Receiving Salmeterol (Serevent)
Prior to administration: Assess for presence/history of chronic asthma, exercise induced asthma, acute asthma attacks, and acute upper airway obstruction. Assess respiratory rate and lung sounds, pulse
PM-03 PED ALLERGY/ANAPHYLAXIS. Protocol SECTION: PM-03 PROTOCOL TITLE: PED ALLERGY/ANAPHYLAXIS REVISED: 01MAY2018
SECTION: PROTOCOL TITLE: REVISED: 01MAY2018 BLS SPECIFIC CARE: See General Pediatric Care Protocol PM-1 - Determine patient s color category on length based resuscitation tape (Broselow Tape) Epi Pen Protocol
The Safety of Asthma and Allergy Medications in Pregnancy: New Horizons
The Safety of Asthma and Allergy Medications in Pregnancy: New Horizons Jennifer Namazy, MD Division of Allergy Scripps Clinic, San Diego Michael Schatz, MD, MS Department of Allergy Kaiser Permanente,
History & Development
RSPT 2317 Anticholinergic Bronchodilators () History & Development Prototypical parasympatholytic agent is atropine an alkaloid found naturally in the plants Atropa belladona (nightshade) and Datura species
Next page. Name MRN DOB Date. Telephone H W M. Pharmacy
University of Texas Medical School at Houston Department of Otorhinolaryngology- Head & Neck Surgery Texas Sinus Institute www.ut-ent.org New Patient Questionnaire Rev. 2014-07-19 FINAL REV Page 1 of 7
CLINICAL MEDICAL POLICY
CLINICAL MEDICAL POLICY Policy Name: Xolair (omalizumab) Policy Number: MP-051-MD-DE Responsible Department(s): Medical Management; Clinical Pharmacy Provider Notice Date: 10/01/2017 Original Effective
Breath of Fresh Air. for the health of the nation, stated in Healthy People 2010,
Volume 7, No. 4 Spring 2003 Asthma Trends in the United States In 1996, when asked During the past 12 months, have you had asthma?, 14.6 million Americans responded yes on behalf of themselves or their
ASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
ASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015
ASTHMA BEST PRACTICES FOR SCHOOL NURSES School Nurses November 2015 1 BACKGROUND AND CURRENT STATS General definitions and explanations 2 Incidence of Asthma Centers for Disease Control (CDC) - 1 in 12
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32
Medicine Dr. Kawa Lecture 4 - Treatment of asthma :
Medicine Dr. Kawa Lecture 4 - Treatment of asthma : Avoiding allergens. Hyposensitization :Subcutaneous injections of inially very small, but gradually increasing doses of allergens (desensitization or
End Stage COPD Guidance Document
End Stage COPD Guidance Document Suggested Guidelines for the Determination of Hospice Eligibility A patient with severe chronic pulmonary disease that meets the following criteria may be eligible for
Chapter 3: Respiratory System (7 th Edition)
Chapter 3: Respiratory System (7 th Edition) The Sheffield respiratory guidelines (April 2015) have been removed from the intranet. This is because the COPD section has been superseded by the COPD treatment
1. What is delayed sequence intubation? Can it be used for severe Asthma exacerbation? 2. What about pregnancy and Asthma is so important?
Chapter 073 Asthma Episode Overview 1. 10 different causes of a wheeze. 2. List 8 risk factors for death from asthma 3. List 6 objective findings of severe asthma 4. 10 therapies for an acute severe asthma
Family Self-Care and Over the Counter Medications Program. Sponsored by: FAHC Department of Pharmacy
Family Self-Care and Over the Counter Medications Program Sponsored by: FAHC Department of Pharmacy What are Over the Counter Medications? Nonprescription medications and products Often referred to as
MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
Bronchial Asthma and COPD
Bronchial Asthma and COPD Red : important Black : in male / female slides Pink : in female s slides only Blue : in male s slides only Females doctor notes Grey: Males doctor notes OBJECTIVES: Different
FASENRA (benralizumab)
FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
ASTHMA IN THE PEDIATRIC POPULATION
ASTHMA IN THE PEDIATRIC POPULATION SEARCH Rotation 2 August 23, 2010 Objectives Define asthma as a chronic disease Discuss the morbidity of asthma in pediatrics Discuss a few things that a health center
Chapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators Clinical Indications for Use Indication for anticholinergic bronchodilator COPD maintenance Indication for combined anticholinergic and β-agonist
Treatment of Influenza. Dr. YU Wai Cho
Treatment of Influenza Dr. YU Wai Cho Symptomatic Treatment Analgesics/ Antipyretics (avoid aspirin) Adequate fluids Rest Specific Drug Treatment Synthetic amines Amantadine Rimantadine Neuraminidase inhibitors
Review of OTC Cough and Cold Medicines
Review of OTC Cough and Cold Medicines Safety Data Dr Ruth Savage Coughs and Sneezes... Health Canada Decision on OTC Cough & Cold Medicines When assessing risk Committee asked to consider The severity
Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN
Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN Goals of Therapy Asthma Prevent symptoms COPD Reduce COPD symptoms Decrease use of SABAs Maintain normal pulm function & prevent loss
Chapter 32. Airway Pharmacology. Copyright 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Chapter 32 Airway Pharmacology Learning Objectives Analyze three phases that constitute the course of drug action from dose to effect. Describe classes of drugs that are delivered via aerosol route. Compare
COMMON UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN
١ ٢ COMMON UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN Dr mostafavi SN Pediatric Infectious Disease Department Isfahan University of Medical Sciences Case 1 ٣ An 18 month old infant brought with high
Neuro Basics SLO Practice (online) Page 1 of 5
Neuro Basics SLO Practice (online) Page 1 of 5 1) Biogenic amines include ACh, NE, EPI and? a) Melatonin b) Dopamine c) Serotonin d) Histamine e) All of the neurotransmitters listed are biogenic amines.
The clinical quality measures as selected by the Clinical Management subcommittee for 2016 for the adult population are:
For 2016 the Clinical Integration Program is moving its clinical quality measures from the Verisk Healthcare Quality and Risk Measures to the National Committee for Quality Assurance HEDIS based measures.
OTC Cough and Cold Medications for Technicians
OTC Cough and Cold Medications for Technicians Phillip J. Olsen, PharmD Objec:ves Describe what should be considered when an OTC cough and cold medica:on is recommended List what OTC medica:on is used
VACCINE-RELATED ALLERGIC REACTIONS
VACCINE-RELATED ALLERGIC REACTIONS Management of Anaphylaxis IERHA Immunization Program September 2016 VACCINE-RELATED ADVERSE EVENTS Local reactions pain, edema, erythema Systemic reactions fever, lymphadenopathy
Diagnosis and Treatment of Respiratory Illness in Children and Adults Guideline
Member Groups Requesting Changes: Lakeview Clinic Marshfield Clinic Mayo Clinic South Lake Pediatrics Response Report for Review and Comment January 2013 Diagnosis and Treatment of Respiratory Illness
Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.
Asthma Air Flow Limitation In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. True whether reversible, asthma and exercise-induced bronchospasm,
10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C
Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines
Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010
BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Xolair (omalizumab) Commercial HMO/PPO/CDHP HMO/PPO/CDHP: Rx
ARIA. At-A-Glance Pocket Reference 2007
ARIA_Glance_2007_8pg:ARIA_Glance_English 9/14/07 3:10 PM Page 1 ARIA At-A-Glance Pocket Reference 2007 1 st Edition NEW ARIA UPDATE BASED ON THE ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA WORKSHOP REPORT
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
Report generated from BNF with QVH Formulary provided by FormularyComplete ( Accessed Formulary Status.
Report generated from BNF with QVH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 09 10 2015 Title Formulary Status Section TA Number TA Link Annotation A2A Spacer Able Spacer Accolate
Secretary for Health and Family Services Selections for Preferred Products
Secretary for Health and Family Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Secretary for Health and Family Services based